Blood DonationNCT04431180
Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#
A study testing blood donation SMS in people with Blood Donation, run by Guangzhou Blood Center at 1 site in China.
Trial summary
The fight against the spread of the 2019-nCoV epidemic has achieved some success in China, but the epidemic is far from over. A key factor making the epidemic under control in China is the government's call for social distance, which has led to few people going out for donation. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Blood Donation
- What is being tested?
- blood donation SMS
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 403,535 participants
- Where
- 1 siteChina
- Study dates
- 13 Jun 2020to 30 Jun 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Blood donors whose last turning up were between December 10, 2016 to December 10, 2019
Who cannot join
- Blood donors who were deferral by blood screening result and other situations. Blood donors who have indicated that they would not accept urgent recruitment.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19#Second Repeat Trial#
The fight against the spread of the 2019-nCoV epidemic has achieved some success in China, but the epidemic is far from over. A key factor making the epidemic under control in China is the government's call for social distance, which has led to few people going out for donation. As a result, the number of blood donors on the streets has been continuing to decline. The first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 May via emergency recruitment SMS . This second repeat trial has been designed to further confirm the results from the the first recruitment by comparing which information extraction frameworks would be more sensitive to blood donors in emergency situations.
Read the detailed description
Researches has showed that that the information extraction and processing in emergency was different from the normal situation. To understand what information the blood donors are more sensitive to in an environment that may pose a potential threat to themselves, the first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 . This interventional study is the second repeat trail of the first trail. The same with first trail, eligible blood donors in Guangzhou Blood Center has been randomly divided into four groups according to their sociological variables, their interval since last blood donation , their history donation times and the location of their last blood donation. Three groups of donors has been randomly selected as interventional groups, and will receive three kindly of emergency blood donor recruitment SMS respectively. The placebo group donors will only receive a thank-you SMS. One recruitment SMS will emphasize what blood services will do to ensure the safety of blood donors during their donation in 2019-nCoV epidemic,one will shows information about a loss-based framework, while the third one will show information about a benefit-based framework .
- Conditions
- Blood Donation
- Being tested
- blood donation SMS
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
blood donation SMSBehavioural
The literature shows that the information extraction and processing in emergency is different from the normal situation. To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages.
| Study group | Role | What they receive |
|---|---|---|
| SMS with safty ensurance | Experimental | SMS content in this group will be about what blood services will do to ensure the safety of blood donors'life saving donation during 2019-nCoV epidemic. Receives: Behavioral: blood donation SMS |
| SMS with saving life call-1 | Experimental | SMS content in this group will be about calling the blood donors to a life saving donation. Receives: Behavioral: blood donation SMS |
| SMS with saving life call-2 | Experimental | SMS content in this group will be about calling the blood donors to a life saving donation. Receives: Behavioral: blood donation SMS |
| SMS with blood donor day greeting | Placebo comparator | SMS content in this group will be about SMS with blood donor day greeting. Receives: Behavioral: blood donation SMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Blood donation rate
Blood donation rate of donors in each group
Measured: 18days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Jun 2020
- Study start13 Jun 2020 (estimated)
- Primary completion13 Jun 2020 (estimated)
- Study completion30 Jun 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood DonationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 403,535 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Guangzhou Blood Center
- Sponsor type
- Other government
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04431180
- Sponsor's protocol ID
- Recruit Blood Donors via SMS 3
- Status last verified
- Jun 2020
- First submitted
- 12 Jun 2020
- Last updated
- 16 Jun 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Recruit Blood Donors Via SMS With Different Contents During Epidemic of COVID-19#Second Repeat Trial#
- ClinicalTrials.gov ID
- NCT04431180
- Acronym / sponsor ID
- Recruit Blood Donors via SMS 3
- Conditions
- Blood Donation
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 403,535 participants (estimated)
- Lead sponsor
- Guangzhou Blood CenterOther government
- Study start
- 13 Jun 2020 (estimated)
- Primary completion
- 13 Jun 2020 (estimated)
- Study completion
- 30 Jun 2020 (estimated)
- First posted
- 16 Jun 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The fight against the spread of the 2019-nCoV epidemic has achieved some success in China, but the epidemic is far from over. A key factor making the epidemic under control in China is the government's call for social distance, which has led to few people going out for donation. As a result, the number of blood donors on the streets has been continuing to decline. The first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 May via emergency recruitment SMS . This second repeat trial has been designed to further confirm the results from the the first recruitment by comparing which information extraction frameworks would be more sensitive to blood donors in emergency situations.
Detailed description
Researches has showed that that the information extraction and processing in emergency was different from the normal situation. To understand what information the blood donors are more sensitive to in an environment that may pose a potential threat to themselves, the first urgent recruitment of blood donors had been implemented during the period from 30 April to 10 . This interventional study is the second repeat trail of the first trail. The same with first trail, eligible blood donors in Guangzhou Blood Center has been randomly divided into four groups according to their sociological variables, their interval since last blood donation , their history donation times and the location of their last blood donation. Three groups of donors has been randomly selected as interventional groups, and will receive three kindly of emergency blood donor recruitment SMS respectively. The placebo group donors will only receive a thank-you SMS. One recruitment SMS will emphasize what blood services will do to ensure the safety of blood donors during their donation in 2019-nCoV epidemic,one will shows information about a loss-based framework, while the third one will show information about a benefit-based framework .
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| SMS with safty ensurance | Experimental | Behavioral: blood donation SMSSMS content in this group will be about what blood services will do to ensure the safety of blood donors'life saving donation during 2019-nCoV epidemic. |
| SMS with saving life call-1 | Experimental | Behavioral: blood donation SMSSMS content in this group will be about calling the blood donors to a life saving donation. |
| SMS with saving life call-2 | Experimental | Behavioral: blood donation SMSSMS content in this group will be about calling the blood donors to a life saving donation. |
| SMS with blood donor day greeting | Placebo comparator | Behavioral: blood donation SMSSMS content in this group will be about SMS with blood donor day greeting. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- Blood donors whose last turning up were between December 10, 2016 to December 10, 2019
Key exclusion criteria (1 listed)
- Blood donors who were deferral by blood screening result and other situations. Blood donors who have indicated that they would not accept urgent recruitment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| blood donation SMSThe literature shows that the information extraction and processing in emergency is different from the normal situation. To find the most effective emergency recruitment method during an outbreak, we intervened with a well-balanced group of donors by presenting different emergency recruitment text messages. | Behavioural | SMS with blood donor day greeting, SMS with safty ensurance, SMS with saving life call-1, SMS with saving life call-2 |
Primary outcome
Blood donation rate
Time frame: 18days
Blood donation rate of donors in each group
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jun 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Blood Donation
Active, not recruitingPhase 2
Treatment of Hemochromatosis
Hemochromatosis
RecruitingObservational study
Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy
Healthy Volunteer
Not yet recruiting
Cookies for Platelets
Blood Donation
RecruitingPhase 2/3
Autologous Cold-stored Apheresis Platelets
Bleeding, Platelets
RecruitingPhase 4
Improving White Blood Cell Collection From Healthy Donors
Allogeneic Granulocyte Donation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing blood donation SMS in people with Blood Donation, run by Guangzhou Blood Center at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Blood donation rate (time frame: 18days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2020.